RNASEL and neoplasm: TaRiboTAC utilizes bivalent pre-miR-21 binders, a phenylboronic acid-caged RNase L recruiter, a cyclic RGD (cRGD) tumor-homing peptide, and the near-infrared (NIR) fluorophore IR780, yielding RIBOTAC21-BA.